Proactive Investors - Run By Investors For Investors

Chemistree granted conditional use permit for Desert Hot Springs land

Chemistree expects its Desert Hot Springs facility could produce about 50,000 pounds of dried-cannabis flower per year
California Republic
Vancouver-based Chemistree is an investment company focusing on the US cannabis sector

Chemistree Technology Inc (CSE:CHM) (OTCQB:CHMJF) said Tuesday that its subsidiary CHM Desert LLC has won a conditional use permit from local authorities in Desert Hot Springs, California for its 9.55 acre property in the city’s cannabis cultivation-friendly zone.

The conditional use permit will give the green light for cultivation in Chemistree’s two greenhouse buildings in Desert Hot Springs as well as activities in an additional building set up for the processing, manufacturing and distribution of cannabis.

READ: Chemistree Technology ‘confident’ of being granted Desert Hot Springs permit for its new cannabis facility

Chemistree expects its Desert Hot Springs facility could produce about 50,000 pounds of dried-cannabis flower per year. Once fully licensed and constructed, it will have the capacity to process, manufacture and distribute a range of cannabis-related products.

“I am really proud of our California team for getting this conditional use permit from concept to award in less than seven months,” said Karl Kottmeier, Chemistree’s president in a statement. “The City of Desert Hot Springs has proven to be a terrific partner, and we look forward to commencing site works as soon as the permitting process allows.”

Headquartered in Vancouver, Chemistree is an investment company focusing on the US cannabis sector.

Contact Ellen Kelleher at [email protected]

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CHM profile View Profile

Chemistree Technology Inc. Timeline

Related Articles

cannabis plan in sun
February 21 2019
The cannabis company will manufacture, infuse and package branded recreational and wellness products
A visual representation of a drug candidate working in a dog
January 28 2019
The company has reaffirmed its upcoming milestones as it confirmed December quarter achievements.
FSD Pharma facility
Tue
The indoor hydroponic facility will be optimized for large-scale, medical-grade cannabis production and once complete, is expected to have over 3.9 million sq/ft available for production
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use